INSIGHTS

READ THE RELEASE

Expansion Therapeutics News:

Expansion Therapeutics Raises $80 Million Series B...

Site Under Construction

Jan 25

Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development

-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 24, 2022 --...

Jan 19

Expansion Therapeutics Appoints Gary Bridger, Ph.D., to its Board of Directors

-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 19, 2022 -- Expansion...

Sep 29, 2021

Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases

-- Funding to advance the company’s SMiRNA™ platform to identify clinical candidates in myotonic dystrophy type 1 (DM1), amyotrophic...

Jun 14, 2021

Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery

Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery

May 25, 2021

Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research...

Expansion Therapeutics Announces In-Licensing of Two New Research Programs from Scripps Research

May 6, 2021

Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research

Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research

Oct 5, 2020

Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President

Meet Expansion Therapeutics New CEO